Abbreviations used: [Ca 2+ ] i , cytosolic free Ca 2+ concentration; CaM, calmodulin; CPI-17, 17-kDa PKC-potentiated inhibitory protein of PP1; ILK, integrin-linked kinase; LC 17 , 17-kDa light chain of myosin; LC 20 , 20-kDa light chain of myosin; MLCK, myosin light chain kinase; MLCP, myosin light chain phosphatase; MYPT1, myosin-targeting subunit of MLCP; PKC, protein kinase C; ROK, Rho-associated kinase; ZIPK, zipper-interacting protein kinase. Ser19 and diphosphorylation at Ser19 and Thr18 on contraction and relaxation of Triton-skinned rat caudal arterial smooth muscle revealed that phosphorylation at Thr18 has no effect on steady-state force induced by Ser19 phosphorylation. On the other hand, the rates of dephosphorylation and relaxation are significantly slower following diphosphorylation at Thr18 and Ser19 compared to monophosphorylation at Ser19. We propose that this diphosphorylation mechanism underlies the prolonged contractile response of particular vascular smooth muscle tissues to specific stimuli, e.g. endothelin-1 stimulation of renal afferent arterioles, and the vasospastic behavior observed in pathological conditions such as cerebral vasospasm following subarachnoid hemorrhage and coronary arterial vasospasm. ILK and ZIPK may, therefore, be useful therapeutic targets for the treatment of such conditions.
The central role of myosin regulatory light chain phosphorylation in the activation of smooth muscle contraction
Vascular smooth muscle contraction is activated by an increase in cytosolic free Ca 2+ concentration ([Ca 2+ ] i )
as a result of Ca 2+ entry from the extracellular space and/or Ca 2+ release from intracellular stores, primarily the sarcoplasmic reticulum (1) . Ca 2+ diffuses to the contractile machinery where it binds to calmodulin (CaM) (2) . The (Ca
2+
) 4 -CaM complex induces a conformational change in myosin light chain kinase (MLCK), which involves removal of the autoinhibitory domain from the active site, thereby converting the kinase from an inactive to an active state (3) . MLCK is physically bound through its N-terminus to actin filaments and, upon activation, phosphorylates nearby myosin molecules (4) . Myosin II filaments are composed of hexameric myosin molecules, each consisting of two heavy chains and two pairs of light chains (17-kDa essential light chains (LC 17 ) and 20-kDa regulatory light chains (LC 20 )) located in the neck region of the myosin molecule ( Fig. 1 ).
Activated MLCK phosphorylates Ser19 of LC 20 and this simple post-translational modification induces a conformational change that is transmitted to the myosin heads, resulting in actin interaction and a marked increase in the actin-activated MgATPase activity of myosin (5). The energy derived from the hydrolysis of ATP then drives cross-bridge cycling and the development of force or contraction of the muscle. Relaxation follows the removal of Ca 2+ from the cytosol, primarily by CaATPases, which pump Ca 2+ out of the cell and back into the sarcoplasmic reticulum (6) . MLCK is inactivated as Ca 2+ dissociates from CaM and the autoinhibitory domain of MLCK blocks the active site. Phosphorylated myosin is then dephosphorylated by myosin light chain phosphatase (MLCP), a type 1 protein serine/threonine phosphatase (7).
Ca

2+ sensitization
MLCP is a trimeric phosphatase with a 38-kDa catalytic subunit (PP1cδ), a 130-kDa regulatory subunit (MYPT1) and a 21-kDa subunit of uncertain function. MYPT1 targets the phosphatase holoenzyme to myosin and enhances its activity. MLCP is inhibited by both protein kinase C (PKC) and RhoA/Rho-associated kinase 
Myosin regulatory light chain diphosphorylation
The possibility that LC 20 
Evidence of myosin regulatory light chain diphosphorylation in intact smooth muscle tissues
Phosphorylation of LC 20 at Thr18 and Ser19 has been observed in several smooth muscle tissues, e.g.
bovine tracheal smooth muscle in response to neural stimulation or carbachol (18, 19) , rabbit thoracic aorta treated with prostaglandin-F 2α (20, 21) and renal afferent arterioles stimulated with endothelin-1 (22) . LC 20 diphosphorylation has frequently been associated with pathophysiological conditions involving hypercontractility, including cerebral vasospasm (23), coronary (24, 25) and femoral arterial vasospasm (26), intimal hyperplasia (27) and hypertension (28) .
The functional effects of diphosphorylation of myosin regulatory light chains
Early studies comparing the properties of smooth muscle myosin phosphorylated at Ser19 (by low concentrations of MLCK) and at both Thr18 and Ser19 (by high concentrations of MLCK) indicated that the additional phosphorylation at Thr18 increased the actomyosin MgATPase activity some two-to three-fold (12, (29) (30) (31) .
However, the velocity of movement of myosin-coated beads along actin cables (32) or of actin filaments over immobilized myosin in the in vitro motility assay (31) was similar whether LC 20 was phosphorylated at Ser19 alone or at both Thr18 and Ser19. We recently addressed the hypothesis that phosphorylation at Thr18 may enhance the level of steady-state force achieved with Ser19 phosphorylation (13) . To test this hypothesis, we used Triton-skinned rat caudal arterial smooth muscle strips. The objective was to achieve stoichiometric phosphorylation of LC 20 ] to pCa 4.5 in the presence of ATP and relaxation followed removal of Ca 2+ ( Fig. 2A) . When basal force was restored, the tissue was washed several times in pCa 9 solution without ATP to remove all ATP, following which ATPγS was added at pCa 4.5 to elicit closeto-stoichiometric LC 20 thiophosphorylation ( We next addressed the hypothesis that phosphorylation of LC 20 at both Thr18 and Ser19 reduces the rate of dephosphorylation and relaxation compared to phosphorylation at Ser19 alone. To test this hypothesis, LC 20 was phosphorylated at Ser19 only or at both Thr18 and Ser19 to comparable stoichiometry. This was achieved by treatment of Triton-skinned rat caudal arterial smooth muscle strips with ATP at pCa 4.5 (for monophosphorylation at Ser19) or with ATP and the phosphatase inhibitor okadaic acid at pCa 9 (for diphosphorylation at Thr18 and Ser19). The time-courses of dephosphorylation and relaxation were then followed to determine if there was a reduction in the rates of dephosphorylation and relaxation when LC 20 was diphosphorylated at
Thr18 and Ser19 compared to monophosphorylated at Ser19. As shown in Fig. 3A and C, both treatments induced LC 20 phosphorylation to ~ 0.5 mol P i /mol LC 20 . At pCa 4.5, this was exclusively Ser19 phosphorylation, whereas in response to okadaic acid at pCa 9, phosphorylation occurred at both Thr18 and Ser19 (Fig. 3C) .
Comparison of the time-courses of dephosphorylation ( Fig. 3A and C) and relaxation ( Fig. 3B ) clearly shows that both dephosphorylation and relaxation rates were significantly slower when LC 20 was diphosphorylated at
Thr18 and Ser19 compared to monophosphorylated at Ser19. This finding suggests a functional effect of LC 20 diphosphorylation and raises the possibility that pathological situations of hypercontractility may result from impaired relaxation due to this dephosphorylation event. MLCP has been shown to dephosphorylate Thr18 in ] (pCa 4.5) solution containing ATP and an ATP regenerating system (RS), which induced a contractile response. Tissues were then relaxed by 3 washes in pCa 9 solution containing ATP and RS. ATP was then removed by 6 washes in pCa 9 solution without ATP or RS. Tissues were then incubated in pCa 4.5 solution containing ATPγS (4 mM) in the absence of ATP and RS. Excess ATPγS was then removed by washing twice with pCa 9 solution without ATP or RS. Contraction was evoked by transfer to pCa 9 solution containing ATP and RS. Once steady-state force was established, microcystin (1 µM) was added in pCa 9 solution containing ATP and RS. Tissues were harvested at the indicated times during this protocol for Phos-tag SDS-PAGE and western blotting with anti-pan LC 20 addition to Ser19 (38) suggesting that the same phosphatase dephosphorylates mono-and diphosphorylated LC 20 in situ.
The renal microvasculature Fig. 4 provides a schematic representation of the renal microcirculation, which consists of the afferent arteriole conveying blood from the interlobular artery to the glomerular capillaries where it is filtered prior to returning to the systemic circulation via the efferent arteriole. The afferent arteriole plays a key role in regulating glomerular inflow resistance and must be able to respond very rapidly to sudden changes in systemic blood pressure in order to protect the fragile glomeruli from pressure-induced damage (39) . Angiotensin II (Ang II) is a renal-selective vasoconstrictor that contributes to renal vascular resistance under normal physiological conditions and thereby plays an important role in modulating renal hemodynamics (40) . Endothelin-1 (ET-1), on the other hand, is a renal vasoconstrictor that does not contribute to renal vascular resistance under normal physiological conditions, but is implicated in abnormal renal vasoconstriction and reduced glomerular filtration in pathological states such as diabetes and chronic kidney disease (41) (42) (43) (44) (45) (46) (47) .
Based on our studies of the effects of LC 20 diphosphorylation described above, we developed a hypothesis that pathological situations of hypercontractility may result from impaired relaxation due to diphosphorylation identified by using phosphorylation site-specific antibodies in parallel western blotting experiments. We were able to increase the sensitivity of detection of LC 20 > 4,000-fold over existing methods (50) . This was achieved 
